CKD-519

• Description:

  CKD-519 (Rocacetrapib, CKD519) is a potent, selective cholesteryl ester transfer protein (CETP) inhibitor, inhibits the CETP-mediated transfer of cholesteryl ester in human serum with IC50 of 2.3 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  601.606

• Molecular Formula:

  C31H34F7NO3

• Notes:

  Research use only, not for human use.

• Receptor:

  CETP

• CAS Number:

  1402796-27-3